Functional Technologies (TSXV:FEB.H) Debt-to-Revenue : 11.35 (As of Aug. 2012)

View and export this data going back to . Start your Free Trial

What is Functional Technologies Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Functional Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2012 was C$1.41 Mil. Functional Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2012 was C$0.59 Mil. Functional Technologies's annualized Revenue for the quarter that ended in Aug. 2012 was C$0.18 Mil. Functional Technologies's annualized Debt-to-Revenue for the quarter that ended in Aug. 2012 was 11.35.

Functional Technologies Debt-to-Revenue Historical Data

The historical data trend for Functional Technologies's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Functional Technologies Debt-to-Revenue Chart

Functional Technologies Annual Data

Trend

Aug03

Aug04

Aug05

Aug06

Aug07

Aug08

Aug09

Aug10

Aug11

Aug12

Debt-to-Revenue

Get a 7-Day Free Trial

N/A

46.94

8.85

11.35

Functional Technologies Semi-Annual Data
	Aug01	Aug02	Aug03	Aug04	Aug05	Aug06	Aug07	Aug08	Aug09	Aug10	Aug11	Aug12
Debt-to-Revenue	Get a 7-Day Free Trial							N/A	N/A	46.94	8.85	11.35

Competitive Comparison of Functional Technologies's Debt-to-Revenue

For the Biotechnology subindustry, Functional Technologies's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Functional Technologies's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Functional Technologies's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Functional Technologies's Debt-to-Revenue falls into.

Functional Technologies Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Functional Technologies's Debt-to-Revenue for the fiscal year that ended in Aug. 2012 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.41	+	0.588)	/	0.176
	=	11.35

Functional Technologies's annualized Debt-to-Revenue for the quarter that ended in Aug. 2012 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.41	+	0.588)	/	0.176
	=	11.35

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Aug. 2012) Revenue data.

Functional Technologies Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Functional Technologies's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Functional Technologies (TSXV:FEB.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Functional Technologies Corp (TSXV:FEB.H) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.firstventuretech.com

Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.

Functional Technologies (TSXV:FEB.H) Headlines

No Headlines